| Period Ending |
Dec 31, 2013 |
Dec 31, 2012 |
Dec 31, 2011 |
| Total Revenue |
17,506,000 |
12,316,000 |
11,635,000 |
| Cost of Revenue |
13,945,000 |
9,588,000 |
8,074,000 |
|
|
| Gross Profit |
3,561,000 |
2,728,000 |
3,561,000 |
|
|
| |
Operating Expenses |
| |
Research Development |
- |
- |
- |
| |
Selling General and Administrative |
686,000 |
723,000 |
740,000 |
| |
Non Recurring |
794,000 |
3,662,000 |
46,000 |
| |
Others |
314,000 |
304,000 |
291,000 |
| |
|
| |
Total Operating Expenses |
- |
- |
- |
|
|
|
|
| Operating Income or Loss |
2,069,000 |
(1,694,000) |
2,921,000 |
|
|
| |
Income from Continuing Operations |
| |
Total Other Income/Expenses Net |
128,000 |
1,167,000 |
284,000 |
| |
Earnings Before Interest And Taxes |
1,669,000 |
(897,000) |
2,924,000 |
| |
Interest Expense |
227,000 |
77,000 |
44,000 |
| |
Income Before Tax |
1,442,000 |
(974,000) |
2,880,000 |
| |
Income Tax Expense |
548,000 |
(380,000) |
1,123,000 |
| |
Minority Interest |
(170,000) |
(175,000) |
(15,000) |
| |
|
| |
Net Income From Continuing Ops |
305,000 |
(1,072,000) |
1,722,000 |
|
|
| |
Non-recurring Events |
| |
Discontinued Operations |
- |
- |
- |
| |
Extraordinary Items |
- |
- |
- |
| |
Effect Of Accounting Changes |
- |
- |
- |
| |
Other Items |
- |
- |
- |
|
|
|
|
| Net Income |
724,000 |
(769,000) |
1,742,000 |
| Preferred Stock And Other Adjustments |
(250,000) |
(171,000) |
(172,000) |
|
|
| Net Income Applicable To Common Shares |
474,000 |
(940,000) |
1,570,000 |
|
1.61(8.76%) 2:27PM EST - Nasdaq Real Time Price